nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.122	0.213	CbGbCtD
Glipizide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0925	0.162	CbGbCtD
Glipizide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0794	0.139	CbGbCtD
Glipizide—CYP3A4—Betamethasone—psoriatic arthritis	0.0794	0.139	CbGbCtD
Glipizide—CYP3A4—Prednisolone—psoriatic arthritis	0.0783	0.137	CbGbCtD
Glipizide—CYP3A4—Prednisone—psoriatic arthritis	0.074	0.129	CbGbCtD
Glipizide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0462	0.0808	CbGbCtD
Glipizide—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00159	0.00372	CcSEcCtD
Glipizide—Vision blurred—Prednisolone—psoriatic arthritis	0.00159	0.00372	CcSEcCtD
Glipizide—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00159	0.00371	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00157	0.00366	CcSEcCtD
Glipizide—Visual impairment—Dexamethasone—psoriatic arthritis	0.00156	0.00364	CcSEcCtD
Glipizide—Visual impairment—Betamethasone—psoriatic arthritis	0.00156	0.00364	CcSEcCtD
Glipizide—Erythema—Triamcinolone—psoriatic arthritis	0.00155	0.00363	CcSEcCtD
Glipizide—Erythema—Methylprednisolone—psoriatic arthritis	0.00155	0.00362	CcSEcCtD
Glipizide—Malaise—Prednisolone—psoriatic arthritis	0.00152	0.00356	CcSEcCtD
Glipizide—Vertigo—Prednisolone—psoriatic arthritis	0.00152	0.00354	CcSEcCtD
Glipizide—Syncope—Prednisolone—psoriatic arthritis	0.00151	0.00354	CcSEcCtD
Glipizide—Eye disorder—Dexamethasone—psoriatic arthritis	0.00151	0.00353	CcSEcCtD
Glipizide—Eye disorder—Betamethasone—psoriatic arthritis	0.00151	0.00353	CcSEcCtD
Glipizide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00148	0.00347	CcSEcCtD
Glipizide—Hypertension—Prednisolone—psoriatic arthritis	0.00146	0.0034	CcSEcCtD
Glipizide—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00145	0.00338	CcSEcCtD
Glipizide—Arrhythmia—Betamethasone—psoriatic arthritis	0.00145	0.00338	CcSEcCtD
Glipizide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00144	0.00337	CcSEcCtD
Glipizide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00144	0.00336	CcSEcCtD
Glipizide—Discomfort—Prednisolone—psoriatic arthritis	0.00142	0.00332	CcSEcCtD
Glipizide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00141	0.0033	CcSEcCtD
Glipizide—Erythema—Dexamethasone—psoriatic arthritis	0.00141	0.00329	CcSEcCtD
Glipizide—Erythema—Betamethasone—psoriatic arthritis	0.00141	0.00329	CcSEcCtD
Glipizide—Malaise—Triamcinolone—psoriatic arthritis	0.0014	0.00327	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—psoriatic arthritis	0.0014	0.00326	CcSEcCtD
Glipizide—Malaise—Methylprednisolone—psoriatic arthritis	0.0014	0.00326	CcSEcCtD
Glipizide—Vertigo—Triamcinolone—psoriatic arthritis	0.00139	0.00326	CcSEcCtD
Glipizide—Syncope—Triamcinolone—psoriatic arthritis	0.00139	0.00325	CcSEcCtD
Glipizide—Vertigo—Methylprednisolone—psoriatic arthritis	0.00139	0.00325	CcSEcCtD
Glipizide—Syncope—Methylprednisolone—psoriatic arthritis	0.00139	0.00325	CcSEcCtD
Glipizide—Oedema—Prednisolone—psoriatic arthritis	0.00138	0.00322	CcSEcCtD
Glipizide—Dysuria—Methotrexate—psoriatic arthritis	0.00138	0.00321	CcSEcCtD
Glipizide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00136	0.00319	CcSEcCtD
Glipizide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00136	0.00318	CcSEcCtD
Glipizide—Shock—Prednisolone—psoriatic arthritis	0.00136	0.00317	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00134	0.00314	CcSEcCtD
Glipizide—Hypertension—Triamcinolone—psoriatic arthritis	0.00134	0.00313	CcSEcCtD
Glipizide—Hypertension—Methylprednisolone—psoriatic arthritis	0.00134	0.00312	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00133	0.00311	CcSEcCtD
Glipizide—Myalgia—Triamcinolone—psoriatic arthritis	0.00132	0.00309	CcSEcCtD
Glipizide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00132	0.00308	CcSEcCtD
Glipizide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00132	0.00308	CcSEcCtD
Glipizide—Eye disorder—Prednisone—psoriatic arthritis	0.00132	0.00308	CcSEcCtD
Glipizide—Anxiety—Methylprednisolone—psoriatic arthritis	0.00131	0.00307	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—psoriatic arthritis	0.00131	0.00306	CcSEcCtD
Glipizide—Flushing—Prednisone—psoriatic arthritis	0.00131	0.00306	CcSEcCtD
Glipizide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00131	0.00305	CcSEcCtD
Glipizide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00131	0.00305	CcSEcCtD
Glipizide—Discomfort—Triamcinolone—psoriatic arthritis	0.00131	0.00305	CcSEcCtD
Glipizide—Discomfort—Methylprednisolone—psoriatic arthritis	0.0013	0.00304	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00128	0.00298	CcSEcCtD
Glipizide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00127	0.00298	CcSEcCtD
Glipizide—Malaise—Betamethasone—psoriatic arthritis	0.00127	0.00297	CcSEcCtD
Glipizide—Malaise—Dexamethasone—psoriatic arthritis	0.00127	0.00297	CcSEcCtD
Glipizide—Oedema—Triamcinolone—psoriatic arthritis	0.00127	0.00296	CcSEcCtD
Glipizide—Vertigo—Dexamethasone—psoriatic arthritis	0.00127	0.00296	CcSEcCtD
Glipizide—Vertigo—Betamethasone—psoriatic arthritis	0.00127	0.00296	CcSEcCtD
Glipizide—Syncope—Dexamethasone—psoriatic arthritis	0.00126	0.00295	CcSEcCtD
Glipizide—Syncope—Betamethasone—psoriatic arthritis	0.00126	0.00295	CcSEcCtD
Glipizide—Arrhythmia—Prednisone—psoriatic arthritis	0.00126	0.00294	CcSEcCtD
Glipizide—Sweating—Methotrexate—psoriatic arthritis	0.00126	0.00294	CcSEcCtD
Glipizide—Shock—Triamcinolone—psoriatic arthritis	0.00125	0.00291	CcSEcCtD
Glipizide—Insomnia—Prednisolone—psoriatic arthritis	0.00125	0.00291	CcSEcCtD
Glipizide—Shock—Methylprednisolone—psoriatic arthritis	0.00124	0.00291	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00124	0.0029	CcSEcCtD
Glipizide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00124	0.00289	CcSEcCtD
Glipizide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00124	0.00289	CcSEcCtD
Glipizide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00124	0.00289	CcSEcCtD
Glipizide—Erythema—Prednisone—psoriatic arthritis	0.00123	0.00287	CcSEcCtD
Glipizide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00122	0.00286	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00122	0.00286	CcSEcCtD
Glipizide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00122	0.00286	CcSEcCtD
Glipizide—Hypertension—Dexamethasone—psoriatic arthritis	0.00122	0.00284	CcSEcCtD
Glipizide—Hypertension—Betamethasone—psoriatic arthritis	0.00122	0.00284	CcSEcCtD
Glipizide—Myalgia—Betamethasone—psoriatic arthritis	0.0012	0.0028	CcSEcCtD
Glipizide—Myalgia—Dexamethasone—psoriatic arthritis	0.0012	0.0028	CcSEcCtD
Glipizide—Anxiety—Betamethasone—psoriatic arthritis	0.0012	0.00279	CcSEcCtD
Glipizide—Anxiety—Dexamethasone—psoriatic arthritis	0.0012	0.00279	CcSEcCtD
Glipizide—Discomfort—Dexamethasone—psoriatic arthritis	0.00118	0.00277	CcSEcCtD
Glipizide—Discomfort—Betamethasone—psoriatic arthritis	0.00118	0.00277	CcSEcCtD
Glipizide—Pain—Prednisolone—psoriatic arthritis	0.00118	0.00275	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—psoriatic arthritis	0.00118	0.00275	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00117	0.00273	CcSEcCtD
Glipizide—Vision blurred—Prednisone—psoriatic arthritis	0.00116	0.0027	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00115	0.0027	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00115	0.00269	CcSEcCtD
Glipizide—Oedema—Betamethasone—psoriatic arthritis	0.00115	0.00269	CcSEcCtD
Glipizide—Oedema—Dexamethasone—psoriatic arthritis	0.00115	0.00269	CcSEcCtD
Glipizide—Insomnia—Triamcinolone—psoriatic arthritis	0.00115	0.00268	CcSEcCtD
Glipizide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00114	0.00267	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00114	0.00266	CcSEcCtD
Glipizide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00114	0.00266	CcSEcCtD
Glipizide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00114	0.00265	CcSEcCtD
Glipizide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00114	0.00265	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—psoriatic arthritis	0.00113	0.00265	CcSEcCtD
Glipizide—Shock—Dexamethasone—psoriatic arthritis	0.00113	0.00264	CcSEcCtD
Glipizide—Shock—Betamethasone—psoriatic arthritis	0.00113	0.00264	CcSEcCtD
Glipizide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00113	0.00264	CcSEcCtD
Glipizide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00113	0.00263	CcSEcCtD
Glipizide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00113	0.00263	CcSEcCtD
Glipizide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00112	0.00261	CcSEcCtD
Glipizide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00111	0.0026	CcSEcCtD
Glipizide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00111	0.0026	CcSEcCtD
Glipizide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00111	0.0026	CcSEcCtD
Glipizide—Malaise—Prednisone—psoriatic arthritis	0.00111	0.00258	CcSEcCtD
Glipizide—Vertigo—Prednisone—psoriatic arthritis	0.0011	0.00257	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—psoriatic arthritis	0.0011	0.00257	CcSEcCtD
Glipizide—Syncope—Prednisone—psoriatic arthritis	0.0011	0.00257	CcSEcCtD
Glipizide—Anorexia—Dexamethasone—psoriatic arthritis	0.0011	0.00256	CcSEcCtD
Glipizide—Anorexia—Betamethasone—psoriatic arthritis	0.0011	0.00256	CcSEcCtD
Glipizide—Urticaria—Prednisolone—psoriatic arthritis	0.00109	0.00256	CcSEcCtD
Glipizide—Pain—Triamcinolone—psoriatic arthritis	0.00108	0.00253	CcSEcCtD
Glipizide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00108	0.00252	CcSEcCtD
Glipizide—Hypertension—Prednisone—psoriatic arthritis	0.00106	0.00247	CcSEcCtD
Glipizide—Chills—Methotrexate—psoriatic arthritis	0.00106	0.00247	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00105	0.00245	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00105	0.00245	CcSEcCtD
Glipizide—Myalgia—Prednisone—psoriatic arthritis	0.00104	0.00244	CcSEcCtD
Glipizide—Arthralgia—Prednisone—psoriatic arthritis	0.00104	0.00244	CcSEcCtD
Glipizide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00104	0.00244	CcSEcCtD
Glipizide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00104	0.00243	CcSEcCtD
Glipizide—Anxiety—Prednisone—psoriatic arthritis	0.00104	0.00243	CcSEcCtD
Glipizide—Insomnia—Dexamethasone—psoriatic arthritis	0.00104	0.00243	CcSEcCtD
Glipizide—Insomnia—Betamethasone—psoriatic arthritis	0.00104	0.00243	CcSEcCtD
Glipizide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00103	0.00242	CcSEcCtD
Glipizide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00103	0.00241	CcSEcCtD
Glipizide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00103	0.00241	CcSEcCtD
Glipizide—Discomfort—Prednisone—psoriatic arthritis	0.00103	0.00241	CcSEcCtD
Glipizide—Erythema—Methotrexate—psoriatic arthritis	0.00103	0.0024	CcSEcCtD
Glipizide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00102	0.00237	CcSEcCtD
Glipizide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00101	0.00236	CcSEcCtD
Glipizide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00101	0.00236	CcSEcCtD
Glipizide—Urticaria—Triamcinolone—psoriatic arthritis	0.00101	0.00235	CcSEcCtD
Glipizide—Urticaria—Methylprednisolone—psoriatic arthritis	0.001	0.00235	CcSEcCtD
Glipizide—Oedema—Prednisone—psoriatic arthritis	0.001	0.00234	CcSEcCtD
Glipizide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000999	0.00233	CcSEcCtD
Glipizide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000999	0.00233	CcSEcCtD
Glipizide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000999	0.00233	CcSEcCtD
Glipizide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000992	0.00232	CcSEcCtD
Glipizide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000992	0.00232	CcSEcCtD
Glipizide—Shock—Prednisone—psoriatic arthritis	0.000985	0.0023	CcSEcCtD
Glipizide—Pain—Dexamethasone—psoriatic arthritis	0.000983	0.0023	CcSEcCtD
Glipizide—Pain—Betamethasone—psoriatic arthritis	0.000983	0.0023	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000968	0.00226	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—psoriatic arthritis	0.000966	0.00226	CcSEcCtD
Glipizide—Anorexia—Prednisone—psoriatic arthritis	0.000954	0.00223	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000951	0.00222	CcSEcCtD
Glipizide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000947	0.00221	CcSEcCtD
Glipizide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000947	0.00221	CcSEcCtD
Glipizide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00094	0.0022	CcSEcCtD
Glipizide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00094	0.0022	CcSEcCtD
Glipizide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000933	0.00218	CcSEcCtD
Glipizide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000931	0.00218	CcSEcCtD
Glipizide—Malaise—Methotrexate—psoriatic arthritis	0.000924	0.00216	CcSEcCtD
Glipizide—Vertigo—Methotrexate—psoriatic arthritis	0.000921	0.00215	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—psoriatic arthritis	0.000918	0.00214	CcSEcCtD
Glipizide—Urticaria—Dexamethasone—psoriatic arthritis	0.000913	0.00213	CcSEcCtD
Glipizide—Urticaria—Betamethasone—psoriatic arthritis	0.000913	0.00213	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000912	0.00213	CcSEcCtD
Glipizide—Dizziness—Prednisolone—psoriatic arthritis	0.000911	0.00213	CcSEcCtD
Glipizide—Asthenia—Triamcinolone—psoriatic arthritis	0.000909	0.00212	CcSEcCtD
Glipizide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000909	0.00212	CcSEcCtD
Glipizide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000909	0.00212	CcSEcCtD
Glipizide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000907	0.00212	CcSEcCtD
Glipizide—Insomnia—Prednisone—psoriatic arthritis	0.000905	0.00212	CcSEcCtD
Glipizide—Paraesthesia—Prednisone—psoriatic arthritis	0.000899	0.0021	CcSEcCtD
Glipizide—Pruritus—Triamcinolone—psoriatic arthritis	0.000896	0.00209	CcSEcCtD
Glipizide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000894	0.00209	CcSEcCtD
Glipizide—Dyspepsia—Prednisone—psoriatic arthritis	0.000881	0.00206	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—psoriatic arthritis	0.000873	0.00204	CcSEcCtD
Glipizide—Myalgia—Methotrexate—psoriatic arthritis	0.000873	0.00204	CcSEcCtD
Glipizide—Decreased appetite—Prednisone—psoriatic arthritis	0.00087	0.00203	CcSEcCtD
Glipizide—Rash—Prednisolone—psoriatic arthritis	0.000869	0.00203	CcSEcCtD
Glipizide—Dermatitis—Prednisolone—psoriatic arthritis	0.000868	0.00203	CcSEcCtD
Glipizide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000865	0.00202	CcSEcCtD
Glipizide—Headache—Prednisolone—psoriatic arthritis	0.000863	0.00202	CcSEcCtD
Glipizide—Discomfort—Methotrexate—psoriatic arthritis	0.000862	0.00201	CcSEcCtD
Glipizide—Constipation—Prednisone—psoriatic arthritis	0.000856	0.002	CcSEcCtD
Glipizide—Confusional state—Methotrexate—psoriatic arthritis	0.000844	0.00197	CcSEcCtD
Glipizide—Dizziness—Triamcinolone—psoriatic arthritis	0.000838	0.00196	CcSEcCtD
Glipizide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000836	0.00195	CcSEcCtD
Glipizide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000825	0.00193	CcSEcCtD
Glipizide—Asthenia—Betamethasone—psoriatic arthritis	0.000825	0.00193	CcSEcCtD
Glipizide—Asthenia—Dexamethasone—psoriatic arthritis	0.000825	0.00193	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000819	0.00191	CcSEcCtD
Glipizide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000819	0.00191	CcSEcCtD
Glipizide—Nausea—Prednisolone—psoriatic arthritis	0.000818	0.00191	CcSEcCtD
Glipizide—Pruritus—Dexamethasone—psoriatic arthritis	0.000813	0.0019	CcSEcCtD
Glipizide—Pruritus—Betamethasone—psoriatic arthritis	0.000813	0.0019	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000809	0.00189	CcSEcCtD
Glipizide—Vomiting—Triamcinolone—psoriatic arthritis	0.000806	0.00188	CcSEcCtD
Glipizide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000804	0.00188	CcSEcCtD
Glipizide—Rash—Triamcinolone—psoriatic arthritis	0.000799	0.00187	CcSEcCtD
Glipizide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000798	0.00186	CcSEcCtD
Glipizide—Anorexia—Methotrexate—psoriatic arthritis	0.000798	0.00186	CcSEcCtD
Glipizide—Rash—Methylprednisolone—psoriatic arthritis	0.000797	0.00186	CcSEcCtD
Glipizide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000796	0.00186	CcSEcCtD
Glipizide—Urticaria—Prednisone—psoriatic arthritis	0.000795	0.00186	CcSEcCtD
Glipizide—Headache—Triamcinolone—psoriatic arthritis	0.000794	0.00185	CcSEcCtD
Glipizide—Headache—Methylprednisolone—psoriatic arthritis	0.000792	0.00185	CcSEcCtD
Glipizide—Abdominal pain—Prednisone—psoriatic arthritis	0.000791	0.00185	CcSEcCtD
Glipizide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000787	0.00184	CcSEcCtD
Glipizide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000787	0.00184	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000762	0.00178	CcSEcCtD
Glipizide—Dizziness—Betamethasone—psoriatic arthritis	0.00076	0.00178	CcSEcCtD
Glipizide—Dizziness—Dexamethasone—psoriatic arthritis	0.00076	0.00178	CcSEcCtD
Glipizide—Insomnia—Methotrexate—psoriatic arthritis	0.000757	0.00177	CcSEcCtD
Glipizide—Nausea—Triamcinolone—psoriatic arthritis	0.000753	0.00176	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000751	0.00176	CcSEcCtD
Glipizide—Nausea—Methylprednisolone—psoriatic arthritis	0.000751	0.00175	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000746	0.00174	CcSEcCtD
Glipizide—Somnolence—Methotrexate—psoriatic arthritis	0.000744	0.00174	CcSEcCtD
Glipizide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000738	0.00172	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000736	0.00172	CcSEcCtD
Glipizide—Vomiting—Betamethasone—psoriatic arthritis	0.000731	0.00171	CcSEcCtD
Glipizide—Vomiting—Dexamethasone—psoriatic arthritis	0.000731	0.00171	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000727	0.0017	CcSEcCtD
Glipizide—Rash—Betamethasone—psoriatic arthritis	0.000725	0.00169	CcSEcCtD
Glipizide—Rash—Dexamethasone—psoriatic arthritis	0.000725	0.00169	CcSEcCtD
Glipizide—Dermatitis—Betamethasone—psoriatic arthritis	0.000724	0.00169	CcSEcCtD
Glipizide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000724	0.00169	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000722	0.00169	CcSEcCtD
Glipizide—Headache—Betamethasone—psoriatic arthritis	0.00072	0.00168	CcSEcCtD
Glipizide—Headache—Dexamethasone—psoriatic arthritis	0.00072	0.00168	CcSEcCtD
Glipizide—Asthenia—Prednisone—psoriatic arthritis	0.000718	0.00168	CcSEcCtD
Glipizide—Pain—Methotrexate—psoriatic arthritis	0.000715	0.00167	CcSEcCtD
Glipizide—Pruritus—Prednisone—psoriatic arthritis	0.000708	0.00165	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000689	0.00161	CcSEcCtD
Glipizide—Diarrhoea—Prednisone—psoriatic arthritis	0.000685	0.0016	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000684	0.0016	CcSEcCtD
Glipizide—Nausea—Betamethasone—psoriatic arthritis	0.000683	0.0016	CcSEcCtD
Glipizide—Nausea—Dexamethasone—psoriatic arthritis	0.000683	0.0016	CcSEcCtD
Glipizide—Urticaria—Methotrexate—psoriatic arthritis	0.000665	0.00155	CcSEcCtD
Glipizide—Dizziness—Prednisone—psoriatic arthritis	0.000662	0.00155	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000661	0.00155	CcSEcCtD
Glipizide—Vomiting—Prednisone—psoriatic arthritis	0.000637	0.00149	CcSEcCtD
Glipizide—Rash—Prednisone—psoriatic arthritis	0.000631	0.00147	CcSEcCtD
Glipizide—Dermatitis—Prednisone—psoriatic arthritis	0.000631	0.00147	CcSEcCtD
Glipizide—Headache—Prednisone—psoriatic arthritis	0.000627	0.00147	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000616	0.00144	CcSEcCtD
Glipizide—Asthenia—Methotrexate—psoriatic arthritis	0.0006	0.0014	CcSEcCtD
Glipizide—Nausea—Prednisone—psoriatic arthritis	0.000595	0.00139	CcSEcCtD
Glipizide—Pruritus—Methotrexate—psoriatic arthritis	0.000592	0.00138	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000572	0.00134	CcSEcCtD
Glipizide—Dizziness—Methotrexate—psoriatic arthritis	0.000553	0.00129	CcSEcCtD
Glipizide—Vomiting—Methotrexate—psoriatic arthritis	0.000532	0.00124	CcSEcCtD
Glipizide—Rash—Methotrexate—psoriatic arthritis	0.000528	0.00123	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—psoriatic arthritis	0.000527	0.00123	CcSEcCtD
Glipizide—Headache—Methotrexate—psoriatic arthritis	0.000524	0.00122	CcSEcCtD
Glipizide—Nausea—Methotrexate—psoriatic arthritis	0.000497	0.00116	CcSEcCtD
